About Us

---

We are building a multiomic diagnostic platform that detects early disease signals from human waste. Our tests analyze urine and stool to identify molecular changes and flag risk factors before symptoms appear.

• Simple, non-invasive sampling that fits into daily life.
• Early signals give people more time and better choices.
• Rich molecular insights from DNA, RNA, proteins, and metabolites.
• Built to scale and fit into clinical routines with ease.

• Screening and monitoring tests that empower early intervention.
• High-sensitivity assays with turnaround times that work in the real world.
• A flexible platform built to expand into new disease areas without starting over.
• Advanced AI and machine learning surface patterns across complex molecular data, unlocking deeper, earlier insights.

Our work is guided by clinical experts and supported by strategic collaborations with biobanks, enabling comprehensive sample collection and deep validation.

1. Collect a simple urine or stool sample using custom preservatives.
2. Extract and profile multiple classes of biomarkers.
3. Analyze with machine learning models that combine signals into a single result.
4. Report actionable insights for both patients and clinicians.

• Health systems and clinics: Partner with us to pilot innovative diagnostics in real-world settings.
• Biobanks and research networks: Collaborate on cohorts to power discovery and validation.
• Patients and communities: Join studies that advance the science of early detection and improve future care.